Brief: Knight Therapeutics Expects To File Its Q1 2020 Financial Results On June 26, 2020
29/05/2020 22:19
May 29 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS INC. ANNOUNCES FURTHER UPDATE ON
EXTENSION
OF FIRST QUARTER 2020 FILINGS DUE TO COVID-19
* KNIGHT THERAPEUTICS INC - CONFIRMS THAT IT EXPECTS TO FILE
ITS
Q1 2020 FINANCIAL RESULTS ON JUNE 26, 2020
Source text for Eikon: ID:nGNX6wRvll
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil